STEPHEN R. BIGGAR, M.D., PH.D. - Corporate Board Profile

ACADIA PHARMACEUTICALS INC

Filing Date	Source Excerpt
2013-04-25	Stephen R. Biggar, M.D., Ph.D. has served as a director since January 2013. He joined the Board after 2012 and did not receive compensation in 2012.
2014-04-23	Stephen R. Biggar, M.D., Ph.D. 43 Director
2015-04-29	Stephen R. Biggar, M.D., Ph.D. has served as a director of our company since January 2013. ... The Board has an Audit Committee and Compensation Committee. Stephen Biggar Fees Earned or Paid in Cash includes Annual Retainer of $35,000 and Additional Retainer for Compensation Member (non-Chair) of $7,000. Option Awards includes the fair value of 12,500 stock options granted June 6, 2014 with an exercise price of $21.99. Total compensation $247,215.
2016-04-29	Stephen R. Biggar, M.D., Ph.D. 45 Director The Board has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The following table provides membership and meeting information for 2015: Stephen Biggar X * During 2015, Dr. Kaplan, who was previously Chair of the Compensation Committee, resigned from the Board of the Directors and all committees of our Board. Following Dr. Kaplan's resignation, Dr. Biggar was appointed as Chair of the Compensation Committee.
2017-04-27	Stephen R. Biggar, M.D., Ph.D. 46 Chairman of the Board and Director
2018-04-30	Stephen R. Biggar, M.D., Ph.D.(3) Fees Earned or Paid in Cash includes Annual Retainer of $50,000, Additional Retainer for Board Chair of $30,000, Additional Retainer for Compensation Chair of $20,000, Additional Retainer for Nominating & Corporate Governance Member (non-Chair) of $5,000. Option Awards includes the fair value of 15,000 stock options granted June 13, 2017 with an exercise price of $27.25. As of December 31, 2017, an aggregate of 81,500 stock options that had been granted to Dr. Biggar were outstanding.
2019-04-30	Stephen R. Biggar, M.D., Ph.D. - Chairman of the Board and Director, age 48. He serves on the Audit Committee (Chair) and Nominating and Corporate Governance Committee. 2018 compensation: $276,284.
2020-04-29	Stephen R. Biggar, M.D., Ph.D., age 49, has served as a director of our company since January 2013. Dr. Biggar is a Partner at Baker Bros. Advisors LP... The following table shows, for the fiscal year ended December 31, 2019, certain information with respect to the compensation of all non-employee directors of the Company during 2019... Stephen R. Biggar, M.D., Ph.D.: Fees Earned or Paid in Cash $105,000, Option Awards $214,959, Total $319,959.
2021-04-30	Stephen R. Biggar, M.D., Ph.D. 50 Chairman of the Board and Director ... "Fees Earned or Paid in Cash" represents an annual retainer as a Board member of $50,000, an additional retainer as Board chair of $30,000, an additional retainer as Compensation Committee chair of $20,000, and an additional retainer as an NCG Committee member (non-chair) of $5,000. "Option Awards" includes the fair value of 5,579 stock options granted June 23, 2020 with an exercise price of $52.73. "Stock Awards" includes the fair value of 3,059 restricted stock units granted June 23, 2020. As of December 31, 2020, an aggregate of 117,079 stock options and 3,059 restricted stock units that had been granted to Dr. Biggar were outstanding.
2022-04-29	Stephen R. Biggar, M.D., Ph.D. 51 Chair of the Board and Director... The following table shows, for the fiscal year ended December 31, 2021, certain information with respect to the compensation of all non-employee directors of the Company during 2021... Stephen R. Biggar, M.D., Ph.D. Fees Earned or Paid in Cash $115,000, Option Awards $167,690, Stock Awards $159,008, Total $441,698.